Vertex Pharmaceuticals Incorporated
VRTX
$472.37
-$2.19-0.46%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/23/2025
-
MarketBeat
4/8/2025
-
Ticker Report
4/8/2025
-
Fool.com Headlines
4/8/2025
-
MarketBeat
4/8/2025
-
Zacks Investment Research
4/8/2025
-
Insider Monkey
4/7/2025
-
GuruFocus
4/7/2025
-
Business Wire
4/7/2025
-
Insider Monkey
4/7/2025
-
Seeking Alpha - Healthcare
4/7/2025
-
SeekingAlpha.com: All News
4/7/2025
-
MarketBeat
4/7/2025
-
The Fly
4/7/2025
-
Business Wire
4/7/2025
-
ETF Channel
4/7/2025
-
Zacks Investment Research
4/7/2025
-
MarketBeat
4/7/2025
-
Fool.com Headlines
4/7/2025
-
StockStory Articles
4/6/2025
-
MarketBeat
4/6/2025
-
MarketBeat
4/6/2025
-
MarketBeat
4/6/2025
-
MarketBeat
4/6/2025
-
MarketBeat
1/16/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 341 6100
Address
50 Northern Avenue
Boston, MA 02210
Boston, MA 02210
Country
Year Founded
Business Description
Sector
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF...
more
